AMRX — AMNEAL PHARMACEUTICALS INC

Ownership history in Capula Management Ltd  ·  2 quarters on record

This page tracks every 13F SEC filing in which Capula Management Ltd reported a position in AMNEAL PHARMACEUTICALS INC (AMRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2025 Q3)
Avg. % of fund
0.01%
First filed
2024 Q2
Last filed
2025 Q3
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 145,300 +19,568 +15.6% 0.01% $1.5M $10.01
2024 Q2 INITIATED 125,732 — — 0.01% $798K —
% of Fund (quarterly)    AMRX price (monthly, adj. close)

Other funds also holding AMRX

As of 2025 Q4 — sorted by position size

TPG GP A, LLC 3Y 5.78% Westshore Wealth, LLC 3Y 5.76% Phocas Financial Corp. 3Y 7Y 2.15% Rubric Capital Management LP 3Y 7Y 1.86% PFM Health Sciences, LP 3Y 7Y 1.84% BlackBarn Capital Partners LP 1.3% Nantahala Capital Management, LLC 3Y 7Y 1.02% Penn Capital Management Company, LLC 3Y 7Y 1.01% Jackson Creek Investment Advisors LLC 3Y 0.83% Informed Momentum Co LLC 3Y 7Y 0.6%
← Back to Capula Management Ltd Holdings